Business · 29/05/2025
FDA Classifies Temporarily-Placed Urethral Opening System for Benign Prostatic Hyperplasia
The FDA has classified the device into Class II (special controls) to ensure its safety and effectiveness, aiming to enhance patients' access to innovative devices while reducing regulatory burdens.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →